首页> 外文期刊>Internal medicine. >Development of Necrotizing Myopathy Following Interstitial Lung Disease with Anti-signal Recognition Particle Antibody
【24h】

Development of Necrotizing Myopathy Following Interstitial Lung Disease with Anti-signal Recognition Particle Antibody

机译:抗信号识别颗粒抗体治疗间质性肺疾病后坏死性肌病的发展

获取原文
           

摘要

A 72-year-old man was admitted due to dyspnea on exertion with interstitial shadows and elevated serum creatinine kinase (CK). Despite a close examination, which included magnetic resonance imaging (MRI), we could not diagnose myopathy. Prednisolone was administered and gradually tapered. One year later, anti-signal recognition particle (SRP) antibody was confirmed and he was re-admitted for hypoxemia with elevated CK. MRI revealed muscle edema and a histopathological examination of a muscle biopsy specimen showed necrotizing myopathy. Prednisolone, cyclosporine, and intravenous immunoglobulin were administered. Physicians should carefully monitor muscle symptoms and serum CK levels in cases of interstitial lung disease with anti-SRP antibodies.
机译:一名72岁的男性因劳累呼吸困难,间质阴影和血清肌酐激酶(CK)升高而入院。尽管进行了仔细检查,其中包括磁共振成像(MRI),但我们仍无法诊断出肌病。给予泼尼松龙并逐渐逐渐减量。一年后,确认了抗信号识别颗粒(SRP)抗体,他因CK升高而被再次接纳低氧血症。 MRI显示肌肉水肿,肌肉活检标本的组织病理学检查显示坏死性肌病。给予泼尼松龙,环孢霉素和静脉注射免疫球蛋白。如果间质性肺疾病使用抗SRP抗体,医生应仔细监测肌肉症状和血清CK水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号